CANCER. The odds of immunotherapy success

Affiliations

¹ Department of Pathology and Immunology, Washington University, St. Louis, MO, USA. mgubin@path.wustl.edu.
² Department of Pathology and Immunology, Washington University, St. Louis, MO, USA.

Comment

Matthew M Gubin et al. Science. 2015.

. 2015 Oct 9;350(6257):158-9.

doi: 10.1126/science.aad4140.

¹ Department of Pathology and Immunology, Washington University, St. Louis, MO, USA. mgubin@path.wustl.edu.
² Department of Pathology and Immunology, Washington University, St. Louis, MO, USA.

No abstract available

Comment on

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.
Van Allen EM, Miao D, Schilling B, Shukla SA, Blank C, Zimmer L, Sucker A, Hillen U, Foppen MHG, Goldinger SM, Utikal J, Hassel JC, Weide B, Kaehler KC, Loquai C, Mohr P, Gutzmer R, Dummer R, Gabriel S, Wu CJ, Schadendorf D, Garraway LA. Van Allen EM, et al. Science. 2015 Oct 9;350(6257):207-211. doi: 10.1126/science.aad0095. Epub 2015 Sep 10. Science. 2015. PMID: 26359337 Free PMC article.